longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Daiichi Sankyo

DSNKY

17.3450.20% ( +0.035 )
Delay Trading: Oct 2, 14:54:19 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 18.76, below the reasonable range, cheaper than 83.93% of the time in the past 3 years, and the industry ranks 35/256, the industry Median -1.31.

18.76xP/E
$17.31Stock price
$0.92Earnings per share
18.76xP/E
Stock price$17.31Earnings per share$0.92

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
27.00x
Typical range
20.01x–46.43x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0285684112

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BMYUSBristol Myers Squibb
13.53x62.25%$125.55B
GSKUSGSK
14.92x14.52%$96.14B
UCBJYUSUCB S.A.
16.97x--$43.23B
HLNUSHaleon
17.70x1.74%$38.41B
OTSKYUSOtsuka Pharmaceutical
14.66x--$37.94B
DSNKYUSDaiichi Sankyo
18.76x--$31.51B
ZTSUSZoetis
10.83x6.81%$28.55B
ALPMYUSAstellas Pharma
11.10x--$25.89B
JAZZUSJazz Pharma
16.08x349.11%$15.13B
OPHLYUSOno Pharmaceutical
14.01x--$6.82B
INDVUSIndivior Pharmaceuticals
11.73x126.83%$4.18B
OGNUSOrganon
17.23x211.11%$3.60B
SNPHYUSSanten Pharmaceutical
14.45x--$3.57B
HYPMYUSHypera S.A.
10.21x--$3.35B
LQDAUSLiquidia Tech
18.08x410.63%$2.51B
HRMYUSHarmony Biosciences
12.71x45.48%$2.30B
PBHUSPrestige Brands
12.33x7.48%$2.12B
ANIPUSANI Pharma
16.46x51.20%$1.64B
GTBIFUSGreen Thumb Industries Inc.
12.41x--$1.57B
PAHCUSPhibro Animal Health
14.60x26.75%$1.46B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.